Women with polycystic ovary syndrome are often depressed or anxious-A case control study

Psychoneuroendocrinology

Volumn 33, Issue 8, 2008, Pages 1132-1138

  Månsson, Mattias ^a   Holte, Jan ^b   Landin Wilhelmsen, Kerstin ^c   Dahlgren, Eva ^c   Johansson, Anette ^a   Landén, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Carl von Linne Clinic   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anxiety disorder; Attempted suicide; Depressive disorder; Eating disorder; Hyperandrogenism; Polycystic ovary syndrome

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ACNE; ANXIETY DISORDER; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG USE; EATING DISORDER; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; INTERVIEW; MENSTRUAL IRREGULARITY; MORBIDITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SELF CONCEPT; SOCIAL PHOBIA; STATISTICAL ANALYSIS; SUICIDE ATTEMPT; SWEDEN; TESTOSTERONE BLOOD LEVEL;

ADULT; ANXIETY; CASE-CONTROL STUDIES; COMORBIDITY; DEPRESSION; EATING DISORDERS; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MIDDLE AGED; PHOBIC DISORDERS; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 49149116599     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.06.003     Document Type: Article

References (57)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th edition (1994), American Psychiatric Publishing
2. Anderson S.E., Cohen P., Naumova E.N., Jacques P.F., and Must A. Adolescent obesity and risk for subsequent major depressive disorder and anxiety disorder: prospective evidence. Psychosom. Med. 69 (2007) 740-747
3. Baischer W., Koinig G., Hartmann B., Huber J., and Langer G. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology 20 (1995) 553-559
4. Balestrieri M., Baldacci S., Bellomo A., Bellantuono C., Conti L., Perugi G., Nardini M., Borbotti M., and Viegi G. Clinical vs. structured interview on anxiety and affective disorders by primary care physicians. understanding diagnostic discordance. Epidemiol. Psichiatr. Soc. 16 (2007) 144-151
5. Barnard L., Ferriday D., Guenther N., Strauss B., Balen A.H., and Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum. Reprod. 22 (2007) 2279-2286
6. Bruce-Jones W., Zolese G., and White P. Polycystic ovary syndrome and psychiatric morbidity. J. Psychosom. Obstet. Gynaecol. 14 (1993) 111-116
7. Chang R.J. The reproductive phenotype in polycystic ovary syndrome. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 688-695
8. Chen T.H., Chang S.P., Tsai C.F., and Juang K.D. Prevalence of depressive and anxiety disorders in an assisted reproductive technique clinic. Hum. Reprod. 19 (2004) 2313-2318
9. Ching H.L., Burke V., and Stuckey B.G. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin. Endocrinol. (Oxf.) 66 (2007) 373-379
10. Cotrufo P., Monteleone P., d'Istria M., Fuschino A., Serino I., and Maj M. Aggressive behavioral characteristics and endogenous hormones in women with Bulimia nervosa. Neuropsychobiology 42 (2000) 58-61
11. Cwikel J., Gidron Y., and Sheiner E. Psychological interactions with infertility among women. Eur. J. Obstet. Gynecol. Reprod. Biol. 117 (2004) 126-131
12. Dumoulin S.C., de Glisezinski I., Saint-Martin F., Jamrozik S.I., Barbe P., Thouvenot J.P., Plantavid M.M., Bennet A.P., and Louvet J.P. Hormonal changes related to eating behavior in oligomenorrheic women. Eur. J. Endocrinol. 135 (1996) 328-334
13. Dunaif A. Adrenal disorders and polycystic ovary syndrome. Horm. Res. 37 (1992) 39-44
14. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
15. Elsenbruch S., Hahn S., Kowalsky D., Offner A.H., Schedlowski M., Mann K., and Janssen O.E. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88 (2003) 5801-5807
16. Franks S. Polycystic ovary syndrome. N. Engl. J. Med. 333 (1995) 853-861
17. Franks S., McCarthy M.I., and Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int. J. Androl. 29 (2006) 278-285 (discussion 286-290)
18. Goodarzi M.O., and Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 20 (2006) 193-205
19. Gorwood P. Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy?. Eur. Psychiatry. 19 (2004) 27-33
20. Goudas V.T., and Dumesic D.A. Polycystic ovary syndrome. Endocrinol. Metab. Clin. North Am. 26 (1997) 893-912
21. Hashimoto D.M., Schmid J., Martins F.M., Fonseca A.M., Andrade L.H., Kirchengast S., and Eggers S. The impact of the weight status on subjective symptomatology of the polycystic ovary syndrome: a cross-cultural comparison between Brazilian and Austrian women. Anthropol. Anz. 61 (2003) 297-310
22. Heo M., Pietrobelli A., Fontaine K.R., Sirey J.A., and Faith M.S. Depressive mood and obesity in US adults: comparison and moderation by sex, age, and race. Int. J. Obes (Lond.) 30 (2006) 513-519
23. Hollinrake E., Abreu A., Maifeld M., Van Voorhis B.J., and Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil. Steril. 87 (2007) 1369-1376
24. Holte J. Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?. J. Endocrinol. Invest. 21 (1998) 589-601
25. Hughes C., Elgasim M., Layfield R., and Atiomo W. Genomic and post-genomic approaches to polycystic ovary syndrome-progress so far: mini review. Hum. Reprod. 21 (2006) 2766-2775
26. Jahanfar S., Eden J.A., and Nguyent T.V. Bulimia nervosa and polycystic ovary syndrome. Gynecol. Endocrinol. 9 (1995) 113-117
27. Jahanfar S., Maleki H., and Mosavi A.R. Subclinical eating disorder, polycystic ovary syndrome - is there any connection between these two conditions through leptin - a twin study. Med. J. Malaysia 60 (2005) 441-446
28. Landén M., Baghaei F., Rosmond R., Holm G., Björntorp P., and Eriksson E. Dyslipidemia and high waist-hip ratio in women with self-reported social anxiety. Psychoneuroendocrinology 29 (2004) 1037-1046
29. Legro R.S. Polycystic ovary syndrome: the new millenium. Mol. Cell Endocrinol. 184 (2001) 87-93
30. Lindén-Hirschberg A., Naessén S., Stridsberg M., Byström B., and Holte J. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol. Endocrinol. 19 (2004) 79-87
31. Martinez-Bermejo E., Luque-Ramirez M., and Escobar-Morreale H.F. Obesity and the polycystic ovary syndrome. Minerva Endocrinol. 32 (2007) 129-140
32. Matsuoka Y., Nishi D., Nakajima S., Kim Y., Homma M., and Otomo Y. Incidence and prediction of psychiatric morbidity after a motor vehicle accident in Japan: the Tachikawa Cohort of motor vehicle accident study. Crit. Care Med. 36 (2008) 74-80
33. McCluskey S., Evans C., Lacey J.H., Pearce J.M., and Jacobs H. Polycystic ovary syndrome and bulimia. Fertil. Steril. 55 (1991) 287-291
34. McCluskey S.E., Lacey J.H., and Pearce J.M. Binge-eating and polycystic ovaries. Lancet 340 (1992) 723
35. Michelmore K.F., Balen A.H., and Dunger D.B. Polycystic ovaries and eating disorders: are they related?. Hum. Reprod. 16 (2001) 765-769
36. Naessen S., Carlstrom K., Bystrom B., Pierre Y., and Hirschberg A.L. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women. Psychoneuroendocrinology 32 (2007) 548-554
37. Naessen S., Carlstrom K., Garoff L., Glant R., and Hirschberg A.L. Polycystic ovary syndrome in bulimic women-an evaluation based on the new diagnostic criteria. Gynecol. Endocrinol. 22 (2006) 388-394
38. Ovesen P.G., Moller N., Greisen S., and Ingerslev H.J. Polycystic ovary syndrome I. Clinical presentation and treatment. Ugeskr Laeger 160 (1998) 260-264
39. Pan A., Ye X., Franco O.H., Li H., Yu Z., Zou S., Zhang Z., Jiao S., and Lin X. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the nutrition and health of aging population in China study. J. Affect. Disord. (2007)
40. Papakostas G.I. Limitations of contemporary antidepressants: tolerability. J. Clin. Psychiatry 68 Suppl. 10 (2007) 11-17
41. Papakostas G.I., Petersen T., Iosifescu D.V., Burns A.M., Nierenberg A.A., Alpert J.E., Rosenbaum J.F., and Fava M. Obesity among outpatients with major depressive disorder. Int. J. Neuropsychopharmacol. 8 (2005) 59-63
42. Raphael F.J., Rodin D.A., Peattie A., Bano G., Kent A., Nussey S.S., and Lacey J.H. Ovarian morphology and insulin sensitivity in women with bulimia nervosa. Clin. Endocrinol. (Oxf.) 43 (1995) 451-455
43. Rasgon N.L., Rao R.C., Hwang S., Altshuler L.L., Elman S., Zuckerbrow-Miller J., and Korenman S.G. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J. Affect. Disord. 74 (2003) 299-304
44. Roberts R.E., Deleger S., Strawbridge W.J., and Kaplan G.A. Prospective association between obesity and depression: evidence from the Alameda County Study. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 514-521
45. Rosenfield R.L. Clinical review: identifying children at risk for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 92 (2007) 787-796
46. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81 (2004) 19-25
47. Seidell J.C., Cigolini M., Deurenberg P., Oosterlee A., and Doornbos G. Fat distribution, androgens, and metabolism in nonobese women. Am. J. Clin. Nutr. 50 (1989) 269-273
48. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., and Dunbar G.C. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 Suppl. 20 (1998) 22-33 quiz 34-57
49. Simon G.E., Von Korff M., Saunders K., Miglioretti D.L., Crane P.K., van Belle G., and Kessler R.C. Association between obesity and psychiatric disorders in the US adult population. Arch. Gen. Psychiatry 63 (2006) 824-830
50. Sundblad C., Bergman L., and Eriksson E. High levels of free testosterone in women with bulimia nervosa. Acta Psychiatrica Scandinavica 90 (1994) 397-398
51. Sundblad C., Landén M., Eriksson T., Bergman L., and Eriksson E. Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa: a placebo-controlled pilot study. J. Clin. Psychopharmacol. 25 (2005) 85-88
52. Timonen M., Laakso M., Jokelainen J., Rajala U., Meyer-Rochow V.B., and Keinanen-Kiukaanniemi S. Insulin resistance and depression: cross sectional study. Bmj 330 (2005) 17-18
53. Urbanek M. The genetics of the polycystic ovary syndrome. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 103-111
54. Vermeulen A., Verdonck L., and Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84 (1999) 3666-3672
55. Weber B., Lewicka S., Deuschle M., Colla M., and Heuser I. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology 25 (2000) 765-771
56. Weiner C.L., Primeau M., and Ehrmann D.A. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom. Med. 66 (2004) 356-362
57. Winokur A., Maislin G., Phillips J.L., and Amsterdam J.D. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am. J. Psychiatry 145 (1988) 325-330